INTRODUCTION
Viral infection results in the activation of host defence mechanisms which have evolved to block the production of progeny virions and to identify and eradicate infected cells. Amongst these mechanisms production of the interferons (IFNs), establishes an antiviral state wherein viral replication is inhibited. In addition, IFN-dependent induction of HLA expression, to give one example, critically enhances the immune response. It is not surprising, therefore, that a number of viruses have evolved mechanisms to counter the IFN response.
The replication of adenoviruses in human cells is relatively resistant to IFN treatment, partly due to the expression of the virus-associated (VA) RNAs. These short RNAs bind to the IFNinducible double-stranded (ds) RNA-dependent protein kinase and prevent its activation (1 -3) . A similar function has recently been ascribed to the EBER RNAs of Epstein-Barr virus (4) . An additional mechanism was suggested when it was shown that infection by wild-type adenovirus, but not an ElA-defective mutant, could inhibit the establishment of the antiviral state (5) . The induction of certain cellular genes by a-IFN was subsequently shown to be inhibited either by infection with wildtype Ad5 or by expression of El A in a transient co-transfection assay (6) .
At early times of infection and in transformed cells the El A gene expresses 12S and 13S mRNAs by differential splicing of a single primary transcript. The protein products have identical amino and carboxy termini but differ by 46 internal amino acid residues unique to the larger protein. Comparison of amino acid sequences from different adenovirus serotypes identified three highly conserved regions. Conserved region (CR) 3, unique to the 13S mRNA products, is required for transactivation of viral early genes by El A. CR1 and CR2 are involved in cell transformation, induction of cellular DNA synthesis and transcriptional repression of viral and cellular genes (7) .
Here, the development of human cell lines stably expressing the 12S or 12S plus 13S El A products has permitted the detailed examination of the effects of such expression on gene induction in response to a-and 7-IFNs and double-stranded RNA (dsRNA).
MATERIALS & METHODS

Growth of cells, transfections, CAT assays and IFN treatment
HeLa and HT1080 (human fibrosarcoma) cells were provided by Drs. Hartmut Land and Peter Goodfellow (ICRF) and were cultured as monolayers in Dulbeccos modified Eagle medium supplemented with 10% foetal calf serum. DNA transfections and CAT assays were performed as previously described (8) . Stable transfectants were generated by co-transfection of pTKneo and subsequent selection in medium containing 400 uglnA of G418. A highly purified mixture of human a-IFNs was provided by Wellcome Research Laboratories, Beckenham, UK 
Plasmids
The IFN-inducible CAT constructs 203.2.14, 474.1.1 and pPAWcatb' have been described previously (8, 10) , as have plasmids pCe (Ad5 E1A), JF12 (Ad5 E1A 12S alone), JN20 (Ad5 El A 13S alone), G5/3 (CR1 deletion) and G3/2 (CR2 deletion), which were kindly provided by Dr N.Jones, ICRF (11) .
RNA isolation and analysis
Cytoplasmic RNA was prepared from monolayer cells by NP40 lysis and phenol-chloroform extraction and analysed by northern transfer as described previously (8) . RNase protection analysis (12) was performed using probes yielding protected fragments of 190 and 270 bp for 6-16 and /3-IFN (kindly provided by Dr Stephen Goodbourn, ICRF), and 160 and 130 bp for 9-27 and 7-actin respectively. Probes were generated using SP6 polymerase to incorporate [^UTP (>400Ci/mmol, Amersham PB. 10163) to an activity of 2 x 10 6 cpm per ng of input plasmid DNA, and 3 X10
5 cpm of each labelled RNA probe was used to protect 10 /tg of cytoplasmic RNA in each assay.
Immuneprecipitation analysis
Monolayer cells (9 cm dish) were incubated for 4hr in 3 ml of methionine-free medium containing 200 /iCi [ 35 S]methionine (>1000Ci/mmol, Amersham SJ1015). Labelled cells were harvested, washed in PBS and lysed in RIPA buffer (13) . Lysates were pre-cleared with protein A (crude cell suspension, Sigma). After incubation for 1 hr at 4°C with either control serum or hybridoma supernatants of M73 or M2 (14) , kindly provided by Dr N.Jones, protein A (50 jd) was added and incubation continued on a rotator for a further hour at 4°C. Protein complexed with protein A was pelleted, washed three times with lysis buffer, resuspended in 20 fd of sample buffer, boiled for 2 min and analysed by 8% SDS-PAGE. Gels were fixed, fluorographed with Amplify (Amersham) according to the manufacturers instructions, and subjected to autoradiography.
Whole cell protein extracts and band shift analysis
Whole cell protein extracts from cells growing as monolayers were prepared as described (15) . Protein concentrations were normalized using the BioRad protein assay as per the manufacturers instructions. Extracts containing 10 /ig of protein were incubated with a 32 P-labelled 39 bp oligonucleotide TTT-ACAAACAGCAGGAAATAGAAACTTAAGAGAAATACA corresponding to the 9-27 ISRE (underlined) and flanking sequences (15) . DNA-protein complexes were resolved in 6% polyacrylamide gels and visualized by autoradiography. When assaying for the Ect and E7 subunits of factor E the individual extracts were mixed and incubated for 10 min at room temperature prior to addition of probe. Treatment of extracts with N-ethyl maleimide (NEM) to inactivate E7 was as described (16) .
IFN receptor assays
Interferon binding assays were as described previously (17, 18 Relative CAT control plasmid HeLa cells with plasmids designed to express either 12S or 13S E1A mRNAs (11) . Lysates prepared from the transfected cells, with or without IFN treatment, were assayed for CAT activity (Table I) . Co-transfection with the 12S El A expression construct inhibited the response to a-or -y-IFNs of all of the IFN-inducible constructs tested (Table IA) . This inhibition does not appear to reflect an effect on transcription mediated through a promoter element independent of the ISRE. For each of the constructs, the ISRE is adjacent to very different promoter elements and in one of the constructs the ISRE is 5' of the herpes simplex virus thymidine kinase (tk) promoter, which is itself insensitive to inhibition by 12S E1A (Table IB ). In addition, high level constitutive CAT expression from a construct under the control of the Rous sarcoma virus long terminal repeat was not inhibited by co-expression of 12S El A (Table IB, cf. 19), arguing against any general effect on transcription in these cells. A 12S E1A gene product, therefore, appears capable of inhibiting the response to a-or 7-IFNs. Increasing the molar excess of the ElA-expressing plasmid co-transfected with the IFN-inducible constructs increased the level of inhibition (not shown). An inhibitory effect on IFN-inducible expression from the CAT constructs was also observed on co-expression of the 13S El A construct (Table IA ). In the case of the tk promoter-based ISRE construct (Table IA) this inhibitory effect was superimposed upon a stimulatory effect on basal transcription (Table IB) . A similar stimulatory effect on the tk promoter has been reported (20) .
Isolation of a human cell line stably expressing El A products
Human HT1080 cells were stably transfected with constructs (Methods) expressing 12S E1A or 12S plus 13S E1A. Clones were examined for changes in morphology, and for the expression of El A polypeptides and the a-and 7-IFN receptors. Typical results for a clone expressing the 12S products (HT12S1) are presented (Fig. 1) . The clones show a morphology distinct from that of untransfected cells, growing as very flat, epithelial-like cells ( Fig. 1 A, lower panel) . To assay for the expression of El A, each clone was labelled with [
35 S]methionine and immune precipitations were performed with monoclonal antibodies specific for the 12S and 13S (M73), or uniquely for the 13S (M2), polypeptide products. The HT12S1 cells expressed two major polypeptides which were precipitated by M73 but not by M2 (Fig. IB) ; the higher molecular weight 12S protein migrating just ahead of a non-specific band at 45 kD.. The same two bands, thought to correspond to different phosphorylated forms of the 12S polypeptide (20) , are obtained on translation of the 12S mRNA in a rabbit reticulocyte lysate (Fig. IB) . Here, the higher molecular weight product of the cell-free system is only faintly visible due to a short translation period (15 min); it becomes more pronounced upon extended translation (21) .
It was of obvious importance to determine whether expression of E1A affects the cell surface receptors for a-or 7-IFNs. Receptor assays were, therefore, performed using nor the cell surface numbers of the receptors were significantly affected by expression of 12S ElA (Fig. 1C) . Consistent with this, and with the retention of functional receptors, the Ea subunits are activated normally by a-IFN in the 12S ElAexpressing cells (see below).
Stable expression of ElA inhibits the cellular response to IFNs and the production of /3-EFN in response to dsRNA HT12S1 and parental HT1080 cells were treated with a-or 7-IFNs for various times and the steady-state levels of 6-16 and 9-27 mRNAs assayed by RNase protection (Fig. 2A) . The level of IFN-induced mRNA for 6-16, a gene predominantly inducible by a-IFN, was reduced dramatically in the HT12S1 cell line. The accumulation of 9-27 mRNA in response to a-and 7-IFNs was similarly inhibited. Longer exposure of the autoradiographs indicated that although a response to a-IFN was detectable in HT12S1, the response to 7-IFN appeared to be totally ablated . This is not the case iif HTa/NEM is mixed with extract from 7-IFN-treated HT12S (lane 9), indicating that HTI2S cell extracts are deficient in the E7 subunit.
described above (eg. 24). Accumulation of HLA class II DRa mRNA in response to 7-IFN was, however, similarly inhibited in the HT12S1 cells (not shown). In addition, induction of /3-IFN mRNA in response to dsRNA is inhibited in these cells (Fig. 2B) . Whether or not common factors are involved, clearly more than one pathway is affected. The effect of the 12S El A products on the ability of cells to mount an antiviral response following IFN treatment was addressed by determining the levels of IFN required to confer 50% protection from the cytopathic effects of Semliki Forest Virus (SFV) in HT1080 and HT12S1 cells. Parental HT1080 cells showed a 50% inhibition of the cytopathic effect at IFN concentrations of 1 U/ml (a-IFN) and 50-100 U/ml (7-IFN). Concentrations of up to 1000 U/ml of a-IFN and up to 10000 U/ml 7-IFN were insufficient to prevent the cytopathic effects of SFV in HT12S1 cells.
IFN-induced DNA-binding factor activity is reduced in cells expressing E1A
Whole cell extracts were prepared from HT1080 and HT12S1 cells with or without a 4hr treatment with a-IFN. Band shift analysis was performed using a 39 bp oligonucleotide containing the 14 bp 9-27 ISRE (Methods). Two distinct IFN-dependent complexes were observed (Fig. 3A, lane 2) . The slower migrating complex E (or ISGF3, 24) has previously been shown to be rapidly induced by a-IFN without any requirement for protein synthesis, whereas induction of the faster migrating complex, M (or ISGF2, 25), occurs more slowly and requires protein synthesis (15) . A considerable body of evidence supports positive regulatory activities for both of these factors (discussed by 26). The levels of E and M observed in response to a-IFN were much reduced in the HT12S1 cell extracts (Fig. 3A, lanes 2 & 4) .
Treatment of HT1080 cells with 7-IFN induces the binding of a factor, termed G, which migrates at a similar rate to M, to which it may be highly related (26, 27) . The level of G was also greatly reduced in extracts from HT12S1 cells (not shown).
Active E requires at least two subunits, Ea and E7. Ea is activated on treatment with a-IFN. E7 is constitutive, can be further induced by 7-IFN, but is inactivated by treatment with Methyl maleimide (NEM) (16) . Extracts from a-IFN-treated cells after exposure to NEM contain only Ea, those from 7-IFNtreated cells contain only E7; combination of the two extracts yields functional E. Extracts can, therefore, be assayed for either subunit by complementation with the other (16) . Assays of this type indicate that extracts from a-IFN-treated HT12S1 cells have Ea but lack, or have very much reduced, E7 (Fig.3B) . Expression of the 12S El A appears to inhibit either the synthesis or the activation of E7. Consistent with this, extracts from HT12S1 cells were without effect on preformed E, or on its formation from pre-existing Ea and E7 subunits (not shown).
Sequences within conserved region 1 of El A are required for inhibition of the IFN response
The IFN response was inhibited in transient co-transfection assays with plasmids expressing either 12S or 13S El A (Table IA) . Conserved region (CR) 3, which is unique to the 13S product, must, therefore, be dispensable for this function. To determine whether there is a specific requirement for either of the remaining two conserved regions, transient and stable transfections were carried out with plasmids G5/3 and G3/2 carrying deletions in CR1 and CR2, respectively (11) . In transient transfection assays G3/2 (CR2-ve) gave a wild-type repression of IFN-induced CAT activity, whereas G5/3 (CRl-ve) did not (Fig. 4A) . In stable transfectants the G5/3 (CR1-negative) construct showed a much reduced inhibitory effect on the expression of 6-16 and 9-27 mRNAs in response to a-and 7-IFNs (Fig. 4B) , despite the fact that they were expressing levels of the CR1-deleted El A polypeptides comparable to those observed for cells stably transfected with wild-type El A constructs (not shown). Sequences within CR1 are, therefore, required for the major inhibitory effect.
Simultaneous expression of 12S and 13S El A products is inhibitory
The El A gene products are capable of transactivation or repression of transcription and it is not clear a priori which activity will be dominant in a given situation. Both 12S and 13S products are expressed from the El A gene on adenovirus infection. It was therefore of interest to determine the effect of expression of bodi products of die El A gene in stable transfectants. In cells stably expressing both 12S and 13S mRNAs (Table IA) and either a control plasmid (lanes 1 to 3) or plasmids expressing a wild-type ElA gene (pCe, lanes 4 to 6) orCR2(G3/2, lanes 7 to 9) or CR1 (G5/3, lanes 10 to 12) ElA deletion constructs. Transfections and a-or y-IFN treatment , as indicated, were as described in Table I . The CAT activities represent the average of duplicate plates for one experiment performed three times. B. Expression of a-and 7-IFN-induciMe 6-16 and 9-27 mRNAs in control cells (HT1080) and cells stably transfected with either a 12S ElA construct (HT12S) or an ElA CR1 deletion construct (HTG5/3, Methods). Treatment with IFN was for 6 (a) or 24 (7) hr. Assay of the RNA was by RNase protection with 7-actin serving as an internal control. and EIA proteins (not shown), the expression of 6-16 and 9-27 mRNAs in response to a-and 7-IFNs was inhibited (Fig. 5A ) and the levels of factors E and M were reduced (Fig. 5B) . The antiviral state assayed with SFV was much reduced in these cells compared with the parental HT1080-no protection was observed with 1000 U/ml of a-IFN or 10000 U/ml of 7-IFN. 
DISCUSSION
Expression of the Ad5 EIA oncogene can inhibit the cellular response to IFNs. In transient (Table I) or stable (Figs. 2 and 4B ) transfections, expression of the 12S or 13S EIA products is inhibitory, a finding which correlates with the observed inability of cells to mount an antiviral response to VSV following adenovirus infection (5) . In transient transfections the transcriptional activities of both pBLCAT2 and pRSVCAT are unaffected by co-expression of 12S EIA, indicating that the observed repression is not due to a general inhibition of transcription (Table IB) . In addition, the inhibitory effect is seen with the ISRE in different contexts in a variety of promoters, suggesting an effect (direct or indirect) on a factor(s) involve*! in the IFN response pathways, as indeed was shown to be the case for stable transfectants by band shift assay (Fig. 3A) . Human cell lines stably expressing EIA products have been difficult to obtain. Stable expression of the EIA 12S and 13S mRNAs in HT1080 cells has, however, been reported recently (28), and we have isolated a number of HT1080-derived lines expressing a variety of mutant and wild-type 12S and 13S EIA constructs. It may be that HT1080 cells are more able to support EIA expression than most human cell lines. Although the possibility that altered forms of El A are being expressed in these cells cannot be excluded, it is unlikely that the phenomena examined are artifactual as they mimic the inhibition observed on adenovirus infection (5). Consistent with this, stable transfectants expressing either the El A 12S or both 12 and 13S products showed a much reduced ability to mount an antiviral response.
Expression of the 12S EIA products markedly inhibits the accumulation of 6-16 and 9-27 mRNAs in response to either aor 7-IFNs ( Fig. 2A) . The response to 7-IFN, however, consistently appeared to be the more susceptible. This differential effect was also observed for induction of HLA class I genes; its significance is not known.
The induction of HLA class II genes by 7-IFN is complex and involves a DNA element(s) distinct from ISREs of the type present in the 6-16 and 9-27 genes (e.g. 24). Nevertheless, this induction is inhibited in the HT12S1 E1 A-transfected cells, as indeed is the response of the /3-IFN gene to dsRNA (Fig. 2B) . Thus, a number of induction pathways are affected by EIA, but whether this is through a common factor, or the known ability of EIA to interact with a number of different proteins remains to be established.
In the case of the a-IFN response pathway operating through ISREs of the type present in the 6-16 and 9-27 genes, the amount of the primary transcriptional activator E detectable by band shift assay was much reduced in extracts from HT 12S1 compared with parental cells. The defect appears to be in either the production or activation of the E7 subunit (Fig. 3B) Extracts from HT12S1 cells were unable to prevent either the generation of E from preformed Ea and E7 subunits, or the subsequent binding of the E complex to an ISRE probe in vitro. It is not yet clear whether the defect in the induction of M is secondary to the effect on E, nor is it clear the relation of either to the inhibition of the appearance of G in response to 7-IFN.
The inhibitory effect of El A on IFN-inducible gene expression is dependent on CR1 (Fig. 4A and B) , a domain previously shown to correlate with transcriptional repression. It has not yet been possible, however, to correlate the inhibitory effect on the IFN response with the ability of EIA to interact with a specific protein(s). Offringa et al. (20) have shown a CRI-dependent inactivation of the transcription factor API by EIA. This, however, appears to be by a different mechanism to that involved in the inhibitory effect upon E. In the case of API, EIA affects neither its synthesis nor its ability to interact with DNA: it is the transactivation function of API that is affected (20) . It may well be, however, that the effect on E is secondary to an effect such as that on API and it is the transcription of E7 (and M and G) that is affected. The possibility that El A is affecting the activation of these factors directly, rather than through the inhibition of the transcription of an enzyme or factor required for activation, seems less likely but cannot yet be excluded.
The ability to inhibit IFN action is of obvious advantage to a virus. Adenoviruses would appear to have developed a number of mechanisms for doing this (e.g. 1-3). Nor, hardly surprisingly, are anti-IFN mechanisms restricted to adenoviruses. For example, Aman and von Gabain have recently reported the inhibition of the cell growth inhibitory effects of IFN in cells expressing the Epstein Barr virus EBNA 2 gene (29) , and recent experiments have shown that expression of the hepatitis B virus polymerase inhibits the DFN response. In this latter case inhibition correlates with expression of the terminal protein domain of the complex polymerase gene product and results in defects similar to those seen here in the cells expressing El A, except that it is the Ea rather than the E7 subunit that is affected (30) . It will be of considerable interest and potential clinical importance (30) to see how widespread and various these different anti-IFN mechanisms are.
